6 Stories in coverage 31 approved Programs 41 recruiting Registered trials S-1 Sep 11 Latest SEC filing Sep 21 Latest story
Timeline 6 Pipeline 3 Trials 4
All6 Regulatory1 Trials and readouts3 Filings and people2
Pipeline by stage
Approved 1 Phase 3 1 Phase 1 1
Details
Headquarters New York, NY Incorporated Delaware Industry Pharmaceutical Preparations Formerly Panacea Acquisition Corp (to 2021) Also known as NUVATION, NUVB, Panacea Acquisition Corp How the company describes itself Nuvation Bio develops oncology therapies including taletrectinib, a ROS1 inhibitor; safusidenib, an IDH1 inhibitor for brain tumors; and drug-drug conjugate programs. The company is based in New York, San Francisco, Boston, and Shanghai. source
